Use of proton pump inhibitors may cause squamous epithelial masking of intramucosal carcinoma in Barrett's esophagus

Endoscopy. 2007 Feb:39 Suppl 1:E105-6. doi: 10.1055/s-2006-945174. Epub 2007 Apr 18.

Authors

K Tanaka¹, H Toyoda, S Kadowaki, Y Hamada, R Kosaka, M Yamanaka, I Imoto

Affiliation

¹ Department of Endoscopic Medicine, Mie University School of Medicine, Tsu, Japan.

PMID: 17440852
DOI: 10.1055/s-2006-945174

No abstract available

Publication types

Case Reports

MeSH terms

2-Pyridinylmethylsulfinylbenzimidazoles / adverse effects*
2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use
Adenocarcinoma / diagnosis*
Adenocarcinoma / pathology
Adenocarcinoma / surgery
Aged
Barrett Esophagus / diagnosis*
Barrett Esophagus / pathology
Barrett Esophagus / surgery
Biopsy
Diagnostic Errors
Epithelium / drug effects*
Epithelium / pathology
Esophageal Neoplasms / diagnosis*
Esophageal Neoplasms / pathology
Esophageal Neoplasms / surgery
Esophagitis, Peptic / drug therapy*
Esophagitis, Peptic / pathology
Esophagitis, Peptic / surgery
Esophagoscopy*
Esophagus / drug effects
Esophagus / pathology
Esophagus / surgery
Humans
Male
Mucous Membrane / pathology
Mucous Membrane / surgery
Proton Pump Inhibitors / adverse effects*
Proton Pump Inhibitors / therapeutic use
Rabeprazole

Substances

2-Pyridinylmethylsulfinylbenzimidazoles
Proton Pump Inhibitors
Rabeprazole